Archives for hormonal treatment

The reproductive prognosis of women considering fertility preservation for early stage endometrial cancer

Pietro Gambadauro MD MSc (Med Ed) PhD. Arch Gynecol Obstet. 2020 Nov;302(5):1305-1306. doi: 10.1007/s00404-018-5028-6.
Read More

Short-Term and Long-Term Results of Resectoscopic Myomectomy With and Without Pretreatment With GnRH Analogs in Premenopausal Women.

Campo, Sebastiano; Campo, Vincenzo; Gambadauro, Pietro Obstetrical & Gynecological Survey. 60(12):795-796, December 2005. This is a summary (with editorial comment) of an article that we had previously published on Acta Obstetricia et Gynecologica Scadinavica (read more). Abstract: This paper presents data from a series of 80 premenopausal women who underwent resectoscopic myomectomy. Forty-two patients underwent myomectomy during the first few days of their menses (group A), and 38 were operated on after pretreatment with a GnRH analog consisting of 2 months of intramuscular triptorelin (3.75 mg Decapeptyl; group B). Pretreatment or no pretreatment was the decision of the managing gynecologist.
Read More

Short-term and long-term results of resectoscopic myomectomy with and without GnRH analogs

Sebastiano Campo, Vincenzo Campo and Pietro Gambadauro Department of Obstetrics and Gynecology, Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Largo Gemelli 8, 00168 Rome, Italy. Acta Obstet Gynecol Scand. 2005 Aug;84(8):756-60. OBJECTIVE: The aim of this study was to analyze the safety and efficacy of resectoscopic myomectomy and to evaluate the influence of GnRH analog pretreatment on short- and long-term surgery outcome. METHODS: Data were collected from 80 consecutive resectoscopic myomectomies performed on premenopausal women. Forty-two patients (52.5%) had not received any preoperative medical treatment and in their case surgery was performed during the early proliferative phase (group
Read More